UPDATE 1-Sanofi, AstraZeneca swap compounds in new twist on open drug R&D
November 20, 2015 at 03:03 AM EST
LONDON, Nov 20 (Reuters) - French drugmaker Sanofi and Britain's AstraZeneca said on Friday they had agreed a direct exchange of 210,000 chemical compounds from their respective libraries in a new twist on the drive to boost open innovation.